Evidence map›Paper›PMID 42291988›Full record

ArticleCureus2026

Ayurvedic Management of Post-hysterectomy Osteoporosis: A Case Report.

Yogita Pole, Amit Nakanekar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yogita PoleDepartment of Kayachikitsa, Government Ayurved College and Hospital, Nagpur, Nagpur, IND.
Amit NakanekarDepartment of Kayachikitsa, Government Ayurved College and Hospital, Nagpur, Nagpur, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is a systemic metabolic bone disorder characterized by decreased bone mass and microarchitectural deterioration. These changes increase fragility and fracture risk. The condition is seen particularly in postmenopausal and post-hysterectomy women. Hormone decline-related bone loss is often linked to chronic musculoskeletal pain, functional limitation, and reduced quality of life. Long-term use of modern antiresorptive therapies, though effective, may be limited by tolerability concerns and adherence challenges. This creates a rationale for safer, multimodal conservative approaches. A 55-year-old female with a history of hysterectomy in 2017 presented with a three-month history of generalized musculoskeletal pain predominantly affecting the knees and small joints of the hands, accompanied by thigh discomfort and functional limitation, and associated with generalized weakness, increased fatigue, and reduced mobility, prompting evaluation for underlying metabolic bone disease. She first reported to the OPD on February 4, 2025. Baseline evaluation showed low serum calcium (6.7 mg/dL), and bone density screening using quantitative ultrasound (QUS) of the right tibia showed a T-score of -2.6, which may suggest low bone density, including osteoporosis or possible osteomalacia. She received structured Ayurvedic integrative management over six months, with a short treatment gap due to self-discontinuation and later resumption. Clinically significant improvement was observed across validated outcome measures, including pain reduction, improvement in functional disability, and resolution of exertional limitation. Follow-up assessment demonstrated correction of hypocalcemia and improvement in QUS-based parameters, along with sustained symptomatic relief. This case describes symptomatic and biochemical improvement in a patient receiving an Ayurvedic intervention, with concurrent changes in QUS-based parameters. However, these findings are derived from a single case and a screening modality; hence, despite cautious interpretation, this observation generates a research question to evaluate the Ayurveda-based approach for improvement in bone mineral density or underlying mechanisms. The observations are hypothesis-generating and warrant further investigation using standardized interventions, dual-energy X-ray absorptiometry-based assessment, comprehensive metabolic evaluation, and controlled study designs to establish clinical efficacy, safety, and biological relevance.

Indexed as

ayurvedabasticase reportosteoporosispost-hysterectomy menopause

Identifiers

PMID42291988
PMCPMC13264008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.